- Title
- Coeliac disease is a strong risk factor for Gastro-oesophageal reflux disease while a gluten free diet is protective: a systematic review and meta-analysis
- Creator
- Irani, Mudar Zand; Eslick, Guy D.; Burns, Grace L.; Potter, Michael; Halland, Magnus; Keely, Simon; Walker, Marjorie M.; Talley, Nicholas J.
- Relation
- eClinicalMedicine Vol. 71, Issue May 2024, no. 102577
- Publisher Link
- http://dx.doi.org/10.1016/j.eclinm.2024.102577
- Publisher
- The Lancet Publishing Group
- Resource Type
- journal article
- Date
- 2024
- Description
- Background: Gastro-oesophageal reflux disease (GORD) mechanisms are well described, but the aetiology is uncertain. Coeliac disease (CD), a gluten enteropathy with increased duodenal eosinophils overlaps with GORD. Functional dyspepsia is a condition where duodenal eosinophilia is featured, and a 6-fold increased risk of incident GORD has been observed. Perturbations of the duodenum can alter proximal gastric and oesophageal motor function. We performed a systematic review and meta-analysis assessing the association between CD and GORD. Methods: A systematic search of studies reporting the association of GORD and CD was conducted. CD was defined by combined serological and histological parameters. GORD was defined based on classical symptoms, oesophagitis (endoscopic or histologic) or abnormal 24-h pH monitoring; studies reporting oesophageal motility abnormalities linked with GORD were also included. Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated using a random-effects model. Findings: 31 papers were included. Individuals with CD on a gluten containing diet were 3 times more likely to have GORD than controls (OR: 3.37, 95% CI: 2.09–5.44), and over 10 times more likely when compared to those on a gluten free diet (GFD) (OR: 10.20, 95% CI: 6.49–16.04). Endoscopic oesophagitis was significantly associated with CD (OR: 4.96; 95% CI: 2.22–11.06). One year of a GFD in CD and GORD was more efficacious in preventing GORD symptom relapse than treatment with 8 weeks of PPI in non-CD GORD patients (OR: 0.18, 95% CI: 0.08–0.36). Paediatric CD patients were more likely to develop GORD (OR: 3.29, 95% CI: 1.46–7.43), compared to adult CD patients (OR: 2.55, 95% CI: 1.65–3.93). Interpretation: CD is strongly associated with GORD but there was high heterogeneity. More convincingly, a GFD substantially improves GORD symptoms, suggesting a role for duodenal inflammation and dietary antigens in the aetiology of a subset with GORD. Ruling out CD in patients with GORD may be beneficial.
- Subject
- gastroesophageal reflux disease; coeliac disease; oesophagitis; gluten; gluten-free diet
- Identifier
- http://hdl.handle.net/1959.13/1505573
- Identifier
- uon:55689
- Identifier
- ISSN:2589-5370
- Rights
- x
- Language
- eng
- Reviewed
- Hits: 1107
- Visitors: 1107
- Downloads: 0